Across TCGA pan-cancer cohorts, NXPE2 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated NXPE2 data layer compared with 20 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher NXPE2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NXPE2 expression acts as an unfavorable survival marker.

STAD, UCEC, and LUAD are the cancer types where NXPE2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.250	0.729	.028	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
LUAD	OS	Median	All	0.250	0.672	.015	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: NXPE2 tumor-vs-normal RNA expression · all NXPE2 data types